MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

MDT

95.97

-0.18%↓

A

137.66

+1.08%↑

VEEV

219.44

-1.64%↓

HQY

91.05

-0.5%↓

PHR.US

16.26

-3.79%↓

Search

Cytek Biosciences Inc

Closed

SectorHealthcare

4.91 -2.19

Overview

Share price change

24h

Current

Min

4.9

Max

4.9399999999999995

Key metrics

By Trading Economics

Income

105K

-5.5M

Sales

6.7M

52M

EPS

-0

Profit margin

-10.476

Employees

692

EBITDA

6.4M

-4.2M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+18.5% upside

Market Stats

By TradingEconomics

Market Cap

144M

646M

Previous open

7.1

Previous close

4.91

News Sentiment

By Acuity

17%

83%

14 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Cytek Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Jan 2026, 22:45 UTC

Major Market Movers

GH Research Shares Up, Plans to Provide Update on New Drug Application

4 Jan 2026, 23:50 UTC

Market Talk
Major News Events

Gold Rises Amid Geopolitical Risks After Maduro's Ouster -- Market Talk

4 Jan 2026, 23:50 UTC

Market Talk
Major News Events

Nikkei May Decline After Removal of Venezuela's Maduro -- Market Talk

4 Jan 2026, 23:41 UTC

Market Talk
Major News Events

Global Forex and Fixed Income Roundup: Market Talk

4 Jan 2026, 23:40 UTC

Market Talk
Major News Events

Markets Mostly Calm as Venezuelan Raid Weighed -- Market Talk

4 Jan 2026, 23:35 UTC

Market Talk
Major News Events

Oil Declines on Oversupply Worries After Maduro's Ouster -- Market Talk

4 Jan 2026, 23:19 UTC

Market Talk
Major News Events

Global Energy Roundup: Market Talk

4 Jan 2026, 23:19 UTC

Market Talk
Major News Events

ONGC Could Receive $500M in Unpaid Dividends From U.S. Takeover of Venezuelan Oil -- Market Talk

4 Jan 2026, 23:17 UTC

Major News Events

Spot Gold Rises 0.8% to $4,365.24/oz

4 Jan 2026, 23:16 UTC

Major News Events

Spot Gold Rises After U.S.' Removal of Venezuela's Maduro

4 Jan 2026, 23:14 UTC

Major News Events

Front-Month WTI Crude Oil Futures Fall 0.6%; Front-Month Brent Crude Oil Futures Drop 0.5%

4 Jan 2026, 23:13 UTC

Major News Events

Front-Month Crude Oil Futures Fall After Ouster of Venezuela's Maduro

4 Jan 2026, 23:12 UTC

Market Talk
Major News Events

Reliance Industries' Could Benefit from U.S. Takeover of Venezuelan Oil -- Market Talk

4 Jan 2026, 22:37 UTC

Market Talk
Major News Events

Gold Can Gain From Flight to Quality, Central Bank Demand After Maduro Ouster -- Market Talk

4 Jan 2026, 21:00 UTC

Earnings

An On-Time Jobs Report. Plus, Albertsons, Constellation, Jefferies, and More Stocks to Watch this Week. -- Barrons.com

4 Jan 2026, 20:49 UTC

Market Talk
Major News Events

Global Energy Roundup: Market Talk

4 Jan 2026, 20:49 UTC

Market Talk
Major News Events

Jitters About Potential for U.S. Actions Elsewhere Could Grow -- Market Talk

3 Jan 2026, 18:59 UTC

Major News Events

Update: Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 Jan 2026, 17:42 UTC

Major News Events

The Oil Sector's Biggest Winners and Losers From Venezuela Regime Change -- Barrons.com

3 Jan 2026, 17:40 UTC

Major News Events

Trump Says U.S. Will 'Run' Venezuela After Maduro Is Flown to New York -- Barrons.com

3 Jan 2026, 16:10 UTC

Major News Events

What Maduro's Capture Means for Chevron Stock -- Barrons.com

3 Jan 2026, 15:53 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 Jan 2026, 15:03 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 Jan 2026, 14:10 UTC

Major News Events

Update: Venezuela's Maduro Captured by U.S. and Flown Out of Country, Trump Says -- Barrons.com

3 Jan 2026, 12:16 UTC

Major News Events

U.S. Captures Maduro, Trump Says -- Barrons.com

3 Jan 2026, 09:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

3 Jan 2026, 09:20 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

3 Jan 2026, 00:43 UTC

Acquisitions, Mergers, Takeovers

Research Reports -- Barrons.com

2 Jan 2026, 22:13 UTC

Market Talk
Earnings

Tesla Seen As Quiet on Artificial-Intelligence Efforts -- Market Talk

2 Jan 2026, 21:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

Cytek Biosciences Inc Forecast

Price Target

By TipRanks

18.5% upside

12 Months Forecast

Average 5.83 USD  18.5%

High 7.5 USD

Low 4 USD

Based on 3 Wall Street analysts offering 12 month price targets forCytek Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

3.7 / 3.8Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

14 / 374 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat